STOCK TITAN

Vicarious Surgical to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced its participation in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference. The presentation will be accessible from November 22, 2021, at 10:00 a.m. Eastern Time on their website. Founded in 2014, Vicarious Surgical is innovating surgical procedures using advanced robotics and virtual reality technology, aiming to enhance efficiency and patient outcomes. Their technology is recognized with Breakthrough Device Designation by the FDA, marking a significant milestone in surgical robotics.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference.

A recording of the presentation will be available beginning on Monday, November 22, 2021 at 10:00 a.m. Eastern Time. Interested parties may access the presentation on the “Investors” section of the company’s website at https://investor.vicarioussurgical.com/.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass. Learn more at www.vicarioussurgical.com.

Investor Contact

Lynn Lewis or Marissa Bych

Gilmartin Group

ir@vicarioussurgical.com

Press and Media Inquiries:

Jill Gross

Matter Communications

media@vicarioussurgical.com

Source: Vicarious Surgical Inc.

FAQ

What is the date and time of Vicarious Surgical's presentation at the Piper Sandler Virtual Healthcare Conference?

Vicarious Surgical's presentation is scheduled for November 22, 2021, at 10:00 a.m. Eastern Time.

How can I access the recording of Vicarious Surgical's presentation?

The recording of Vicarious Surgical's presentation will be available on their website under the 'Investors' section.

What innovative technology is Vicarious Surgical developing?

Vicarious Surgical is developing surgical robots combined with virtual reality for minimally invasive surgeries, aiming to improve patient outcomes.

Has Vicarious Surgical received any FDA designations?

Yes, Vicarious Surgical's technology received the Breakthrough Device Designation from the FDA.

Which prominent investors back Vicarious Surgical?

Vicarious Surgical is backed by notable investors including Bill Gates, Khosla Ventures, and AME Cloud Ventures.

Vicarious Surgical Inc.

NYSE:RBOT

RBOT Rankings

RBOT Latest News

RBOT Stock Data

34.15M
5.24M
30.57%
35.94%
2.13%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
WALTHAM